Overexpression of LIM and SH3 protein 1 (LASP1) is required for colorectal cancer (CRC) development and progression. Here, C-Jun activation domain-binding protein-1 (Jab1), also known as COP9 signalosome subunit 5 (COPS5), was verified as a new LASP1-interacting protein through yeast two-hybrid assay. The role of COPS5 in LASP1-mediated CRC progression remains unknown. GST pull-down assay indicated that the SH3 domain of LASP1 could directly bind to MPN domain of COPS5. In vitro gain-and loss-offunction analyses revealed the stimulatory role of COPS5 on CRC cell proliferation, migration and invasion. Endogenous overexpression of COPS5 could also enhance the homing capacity of CRC cells in vivo. Further analysis showed that COPS5 and LASP1 synergistically interact to stimulate the ubiquitination and degradation of 14-3-3r and promote colorectal cancer progression via PI3K/Akt dependent signaling pathway. Clinically, the expression of COPS5 was studied in CRC tissues and it is associated with CRC differentiation, metastasis and poor prognosis. The colocalization of LASP1 and COPS5 was demonstrated in both nonmetastatic and metastatic CRC tissues. A positive correlation was found between the expression of LASP1 and COPS5 while a negative correlation existed between 14-3-3r and COPS5/LASP1 in most CRC samples. A combination of COPS5 and LASP1 tends to be an independent prognostic indicator for CRC patients, and this is also suitable for CRC without lymph node metastasis. The current research has further advanced our understanding on the complicated molecular mechanism underlying LASP1-mediated CRC progression, which hopefully will contribute to the development of novel diagnostic and therapeutic strategies in CRC.
Introduction
Colorectal cancer (CRC) is a worldwide malignancy and its prevalence continues to rise each year. 1 Despite the fact that efforts have been made to improve diagnostic and therapeutic strategies, survival rate of CRC patients remains low within 5 years. 2 The number will further decrease in patients with late-stage CRC. Metastasis is widely believed to be responsible for the high mortality and poor prognosis. 3, 4 Hence, it is urgent to uncover vital molecular mechanisms underlying CRC progression, which helps to figure out potential drug targets and develop new diagnostic strategies. LIM and SH3 protein 1 (LASP1) was initially identified from a cDNA library of breast cancer patient with metastatic axillary lymph nodes. 5 The abnormal expression of LASP1 also exists in several other cancer types including breast cancer, ovarian cancer and CRC. [6] [7] [8] [9] [10] Nuclear LASP-1 is associated with UHRF1-DNMT1-G9a-Snail1 complex and has a direct correlation with the progression breast cancer cells as well as the overall survival of breast cancer patients. 10 Suppression of LASP-1 also attenuates the carcinogenesis of prostatic cancer cell lines through the NFjB pathway. 11 In our previous study, we has validated the overexpression of LASP1 in CRC tissues and it is positively correlated with lymph node metastasis. 12 Upregulation of LASP1 is critical for TGFb-mediated epithelial-mesenchymal transition, aggressive phenotypes of cancer cells and the following cancer progression. 9 MicroRNAs, including miR-1 and miR-133a, inhibit the aggressive effects of LASP1 through directly binding to its 3 0 UTR in CRC cells. 13, 14 Moreover, miR-145 suppresses colon cancer invasion and metastasis by targeting LASP1. 15 In a search for LASP1-modulated proteins involving in tumor progression by comparative proteomic strategies, 16 S100A11 was found interacting with LASP1 to form a LASP1-S100A11 complex, which is essential for TGFb-mediated epithelial-mesenchymal transition and aggressive phenotype of CRC cells. 17 However, the detailed underlying molecular mechanism remains unclear.
In our previous study, we have shown the deletion of 14-3-3r is essential for LASP1-stimulated CRC cell aggressiveness via activating PI3K/AKT signaling pathway. 18 Since LASP1
does not obtain protein degradation capacity, LASP1 might interact with other proteins to downregulate the expression of 14-3-3r at protein level. In our study, COP9 signalosome subunit 5 (COPS5) was identified as a new LASP1-interacting protein using yeast two-hybrid system. The expression and localization of COPS5 were first investigated in both CRC tissues and cell lines. The influence of COPS5 on CRC cell progression was further detected both in vitro and in vivo. We also studied the involvement of COPS5 in LASP1/14-3-3r-mediated CRC progression and corresponding signaling pathways. Finally, clinical significance of COPS5 was analyzed. The current study will undoubtedly deepen our understanding on CRC metastasis and provide experimental basis for COPS5 in improving diagnostic and therapeutic strategies in CRC.
Material and Methods
Cell culture and treatment CRC cell lines including LS174t, RKO, HT29, HCT116, SW480 and SW620 were obtained from the Cell Bank of the Chinese Academy of Sciences (Shanghai, China) and maintained as previously described. 9 A CRC cell subline SW480/M5 with unique liver metastatic potential was established in our laboratory and used in the analysis. All the cells were cultured in RPMI 1640 (Hyclone; Logan, UT) supplemented with 10% fetal bovine serum (FBS; Gibco-BRL, Invitrogen; Paisley, UK) at 378C with a humidity of 5% CO 2 . For inhibitor treatment, CRC cells were treated with PI3K inhibitor LY294002 (Cell Signal Technology, Danvers, MA) every 2 days at a concentration of 10 mM diluted in serum-free medium. Plasmids including pcDNA3-LASP1, pcDNA3-14-3-3r and pcDNA3-COPS5 were constructed in our lab. All siRNA oligos including LASP1 and COPS5 specific siRNAs were purchased from GenePharma (Shanghai, China). CRC cells at exponential growth phase were plated into six-well plates for 24 hr at a density of 0.5 3 10 5 cells/mL and transfected with 1 mg of siRNA or 4 lg cDNA in reduced serum medium (OPTI-MEM-I; Invitrogen) according to the manufacturer's protocol.
Clinical samples
Fresh primary CRC specimens with paired normal colorectal tissues were obtained from the Tumor Tissue Bank of Nanfang Hospital. In each case, pathological diagnosis was made after elective surgery for CRC in Nanfang Hospital during 2007 and 2010. All experiments performed were endorsed by the Ethics Committee of Southern Medical University and complied with the Declaration of Helsinki. No informed consent was required because data were analyzed anonymously.
Two-hybrid assays
CLONETECH MATCHMAKER two-hybrid system (Cat. #k1612-1) was adopted to screen LASP1-interacting proteins in Human Lymphocyte MATCHMAKER cDNA library (Cat. #638801). PBKT7-LASP1-6 plasmid was cotransformed with Human Lymphocyte MATCHMAKER cDNA library to yeast Y190. Cotransformed yeast colonies were plated on the same selective medium to test for protein interaction. The test used a b-galactosidase activity assay in the medium containing 5-30 mM 3-aminotriazole (3-AT) but lacking tryptophan, leucine and histidine. Plasmids were extracted from positive clones and genes with right ORF was sequenced and verified.
GST pull-down assay
(1-61a), GST-LASP1 (1-134a), GST-LASP1 (60-198a), GST-LASP1 (132-261a) and GST-LASP1 (132-198a) were designed as depicted graph showing in Figure 1e . Primers used to amplify truncated proteins were listed in Supporting Information Table  S1 . DNA fragments were sequenced before inserting into pGEX-KG plasmid (Supporting Information Fig. S2 ). GST fusion proteins were expressed in Escherichia coli Bl21 using the pGEX (Pharmacia, Piscataway, NJ) vector system and proteins were purified according to the manufacturer's instruction. We performed pull-down assays by incubating GST fusion protein with RKO whole-cell proteins at RT for 45 min. The beads
What's new?
Overexpression of the proteins LASP1 have been correlated with metastasis in colorectal cancer (CRC). In this study, the authors found that the regulatory protein COPS5 interacts with LASP1 to stimulate CRC cell proliferation, migration and invasion in vitro. In vivo, COPS5 and LASP1 were found to act synergistically to promote CRC progression via the PI3K/Akt-dependent signaling pathway. Clinically, expression of COPS5 was associated with CRC metastasis and poor prognosis. These results should enhance diagnostic and therapeutic strategies in CRC.
were then washed and boiled for western blot assay. The existence of COPS5 and LASP1 were detected in the proteins pulled down by truncated GST-LASP1/COSP5. 
Western blot analysis

RNA isolation, reverse transcription and real-time quantitative PCR
Total RNA was extracted using Trizol reagent according to manufacturer's protocol and our previous report. 19 To quantitate the expression of COPS5, total RNA was polyadenylated and underwent reverse transcription. Real-time quantitative PCR (qPCR) was carried out using SYBR Green PCR master mix (Applied Biosystems; Foster City, CA) on ABI 7500HT system. GAPDH was chosen to be endogenous control. All the primers were synthesized from Invitrogen (Carlsbad, CA). The expression level of each targeted gene was normalized as fold change compared to control or reference group. Fold changes were calculated through relative quantification (
2-DDCT
).
Statistical analysis
Data were analyzed using SPSS statistic software version 19.0 (SPSS; Chicago, IL). The Student's t-test and the one-way ANOVA test were carried out for qRT-PCR. Significance of correlation between the expression of COPS5 and histopathological factors was determined using Pearson's chi-squared (v 2 ) test. The correlation between COPS5 and LASP1 was determined using the Spearman rank correlation test. Kaplan-Meier plots were used to estimate the prognostic relevance of COPS5 in univariate analysis. Multivariate analysis was performed by Cox proportional hazards test. Statistical significance was established at p < 0.05.
Results
COPS5 directly interacted with LASP1 in CRC
To further investigate the mechanism underlying LASP1-mediated CRC cell aggressiveness, yeast two-hybrid assay was used to screen LASP1-interacting proteins. COPS5 with clone name LASP20 was selected from 26 positive clones and it was also one of the 10 clones that obtained the right ORF (Fig. 1a) . Immunofluorescence staining demonstrated the colocalization of COSP5 and LASP1 in frozen tissue sections of CRC (Fig. 1b) . The localization of COPS5 and LASP1 was further studied using CRC cell lines including LS174t, RKO, HT29, HCT116, SW480, SW620 and SW480/M5. Results showed that LASP1 is mainly expressed in the cytoplasm of CRC cells while COPS5 could be found in both cytoplasm and nucleus. A clear colocalization of the two proteins was confirmed in the cytoplasm (yellow) of all CRC cell lines (Fig. 1c) . Interaction of the LASP1 and COPS5 was further validated by coimmunoprecipitation (Co-IP) assay using protein extraction of SW480 and RKO cells (Fig. 1d) . This protein interaction, however, did not influence the expression of the two proteins (Supporting Information Fig. S1 ).
Schematic of COPS5 shows the Jun Binding Domain (JBD) at the N-terminus and the p27 binding domain (PBD) at the C-terminus. COPS5 also contains a nuclear export signal (NES) and a metalloproteinase (MPN) domain (Fig. 1e) . Truncated GST-LASP1 and GST-COPS5 overexpression vectors were constructed to investigate the interaction domains of the two proteins. GST pull-down assay was conducted between GST-LASP1 truncated proteins and RKO whole-cell proteins. COPS5 was only detected by western blot assay after GST-LASP1 (132-261a) and RKO whole-cell proteins undergoing GST pull down (Fig. 1f, left panel) . GST pull-down assay was also conducted between GST-COPS5 truncated proteins and RKO whole-cell proteins. LASP1 was detected after GST-COPS5 (44-195a) and GST-COPS5 (1-195a) undergoing GST pull down (Fig. 1f, right panel) . Western blot results indicated that the SH3 domain of LASP1 could directly bind to MPN domain of COPS5.
Exogenous introduction of COPS5 promotes CRC cell proliferation in vitro
The expression of COPS5 was detected in all CRC cell lines. Western blot assay showed that COPS5 was highly expressed in SW480/M5, LS174t, RKO, SW620 and HT29 cells, while lowly expressed in HCT116, LOVO and SW480 cells (Fig.  2a) . The expression of COPS5 in nonmetastatic CRC originated SW480 cells was markedly lower than lymphatic metastatic CRC originated SW620 cells and hepatic metastatic CRC originated SW480/M5 cells. We successfully constructed COPS5 overexpression lentivirus vector and synthesized two COPS5 siRNAs to study their effect on CRC cells (Fig. 2b) . Infection efficiency was confirmed by monitoring the expression of GFP 48 hr after infection (Supporting Information  Fig. S3 ). CCK-8 assay revealed that exogenous COPS5 significantly enhanced the ability of cell proliferation in COPS5 lowly expressed SW480 and HCT116 cells. Consistently, si-COSP5 suppressed cell proliferation in RKO and SW620 cells with high level of COPS5 expression (Fig. 2c) . The stimulated effect of COPS5 on CRC cell proliferation was also confirmed by colony formation experiments (Fig. 2d) . Cell cycle analysis indicated that COPS5 could increase CRC cell proliferation through promoting cells progressed from G1 phase to M phase. Conversely, knocking down of COPS5 tended to keep cells staying in G1 phase (Fig. 2e) .
COPS5 enhances CRC cell migration and metastasis both in vitro and in vivo
Trans-well and wound-healing assays indicated that exogenous COPS5 markedly increased the migration and motility potential of CRC cells (p < 0.05, Figs. 3a and 3c) . In contrast, si-COPS5 significantly reduced the aggressiveness of CRC cells (p < 0.05, Figs. 3b and 3d ). HCT116 and SW480 cells with stable COPS5 overexpression were injected into the tail vein of nude mice to observe its effect on the potential of homing capacity. More and larger tumor nodules were formed in the lung of COPS5-overexpressing group compared to the control group (Fig. 3e) . The in vivo data further supports COPS5 as a metastasis enhancer. 
COPS5 interacts with LASP1 and suppresses the expression of 14-3-3r in CRC cell lines
Our results indicated that both overexpressing and silencing of LASP1 could not influence the expression of COPS5 and vice versa (Supporting Information Fig. S1 ). COPS5 might interact with LASP1 to influence the expression of LASP1-modulated proteins to stimulate CRC cell aggressiveness. Based on our previous study, we detected the endogenous interaction among COPS5, LASP1 and 14-3-3r by Co-IP in SW480 and RKO cells. Western blot results confirmed the interaction among three proteins (Fig. 4a) . Exogenous COPS5 negatively regulated the expression of 14-3-3r without influence that of LASP1 in both SW480 and HCT116 cells. In consistent, the expression of 14-3-3r was markedly increased in COPS5-silenced RKO and SW620 cells with unchanged expression of LASP1 (Fig. 4b) . Moreover, both COPS5 and LASP1 were silenced simultaneously to study their synergistic role on the expression of 14-3-3r, and a further recovery of the expression of 14-3-3r was detected by western blot analysis (supplementary figure 4) . COPS5 overexpressed-CRC Cells were lysed and purified by anti-14-3-3r affinity gel and protein pellets were analyzed by western blot with anti-ubiquitin. COPS5 increased the ubiquitination and the following protein degradation of 14-3-3r. MG132, which reduces the degradation of ubiquitin-conjugated proteins, could significantly recover the degradation of 14-3-3r induced by COPS5 (Fig. 4C ).
COPS5 and LASP1 synergistically interact to influence CRC cell progression via activating PI3K/AKT pathway
Western blot analysis demonstrated that COPS5 participated in PI3K/Akt pathway via activating Akt (Supporting Information Fig. S4 ). Si-LASP1 markedly restored COPS5-suppressed expression of 14-3-3r, meanwhile neutralized COPS5-activated PI3K/Akt pathway. Similar result was obtained when silencing COPS5 in LASP1-overexpressed CRC cells (Fig. 4d) . Both si-LASP-1 and LY29004 (PI3K/Akt pathway inhibitor) restored COPS5-activated phosphorylation of Akt. Consistently, both si-COPS5 and LY29004 could also restore exogenous LASP1-activated phosphorylation of Akt (Fig. 4e) . All the results above demonstrated that COPS5 and LASP1 interacted synergistically to suppress the expression of 14-3-3r and influence CRC cell progression via PI3K/Akt pathway. This is further confirmed by trans-well assay (Fig. 4f) .
COSP5 is frequently overexpressed in CRC tissues and correlated with poor prognosis of CRC
To evaluate the clinical significances of COPS5, IHC assay was performed in 75 archival paraffin-embedded normal colorectal mucosa and 116 CRC tissues. The immunohistochemical staining was scored semiquantitatively based on the staining intensity of positive tumor cells. Negative (-) and weak (1) samples were scored as low COPS5, while moderate (11) and strong (111) samples were scored as high COPS5 (Fig. 5a ). Increased expression of COPS5 was found accompanied with the progression of CRC (Fig. 5b) . COPS5 was overexpressed in 38.7% (29/75) of normal colorectal samples and a much higher rate was observed in 61.3% (69/ 126) of CRC samples (p < 0.001). The overexpression of COPS5 was closely associated with lymph node metastasis (p 5 0.018) and clinical stage (p 5 0.013) of CRC ( Fig. 5c and Supporting Information Table S3 ). Kaplan-Meier survival analysis revealed a positive correlation between COPS5 expression level and overall survival times (p 5 0.001). Such a relationship was also observed in patients with late-stage CRC (T3 1 T4; p 5 0.001) and even in patients without lymph node metastasis (N0; p 5 0.040). However, multivariate analysis did not propose COPS5 overexpression as an independent prognostic factor for CRC (Supporting Information Table S4 ).
COPS5 interacted with LASP1 negatively regulated the expression of 14-3-3r in CRC tissues
Immunofluorescence histochemical results demonstrated the colocalization of LASP1 and COPS5 in both nonmetastatic and metastatic CRC tissues. The expression of the two proteins is markedly increased in metastatic tissues (Fig. 6a) . Immunohistochemical results from a larger population-based cohort study showed that relatively low expression of 14-3-3r was frequently observed in CRC samples with LASP1 and COPS5 overexpressed (Fig. 6b) . A positive correlation was found between the expression of LASP1 and COPS5 (R 5 0.291, p 5 0.002). There was also a negative correlation between 14-3-3r and COPS5 expression (R 5 20.260, p 50.005). A combination of COPS5 and LASP1 was used to study their predictive value for overall survival. Intriguingly, patients with high LASP1 and high COPS5 had the worst outcome, while patients with low LASP1 and low COPS5 witnessed the best outcome. The combination of LASP1 and COPS5 seems better predicated the prognosis of CRC patients and serves as an independent prognostic factor for CRC ( Fig. 6b and Supporting Information Table S5 ).
Discussion
LASP1, a specific focal adhesion protein, is overexpressed in several metastatic cancers including breast cancer and ovary cancer. [6] [7] [8] In our previous study, LASP1 was also found overexpressing in CRC tissues and its high expression is closely correlated with the poor prognosis of patients with CRC. 9 Obtaining the LIM domain in the N-terminal and SH3 domain in the C-terminal, LASP1 tends to interact with various cytoskeletal and signaling proteins to accomplish its stimulation on cancer aggressiveness. 19 The NH2-terminal of S100A11 interacts with the SH3 domain of LASP1 to form a LASP1-S100A11 protein complex, which is critical for TGFbinitiated EMT and CRC migration.
17 LASP1 could also interact with 14-3-3r to facilitate CRC progression via activating PI3K/AKT signaling pathway. 18 However, the detailed molecular mechanism underlying LASP1-mediated CRC progression remains unclear and new LASP1-interacting proteins still need to be identified.
As a new LASP1-interacting protein, COPS5 was identified from one of the 26 candidates using yeast two-hybrid assay. COPS5 is the fifth subunit of constitutive photomorphogenic-9 signalosome 5 (CSN5), which is widely believed involving in signal transduction, gene transcription and protein stability. [20] [21] [22] It is highly conserved and located in chromosome 8q13.1, an area usually amplified in breast, prostate, colon as well as ovary tumor, and highly related to metastatic phenotype and malignancy progression. COPS5 is a 334aa protein composed of four domains including MPN, NES, PBS and JBS, among which MPN domain is usually involved in protein-protein interactions. 27 In our current study, the MPN domain of COPS5 was demonstrated directly binding to the SH3 domain of LASP1 and their colocalization in the cytoplasm was confirmed both in CRC tissues and CRC cell lines.
Aberrant overexpression of COPS5 has been observed in a variety of human cancers and it is closely related to tumorgenesis. [28] [29] [30] [31] COPS5 is demonstrated involving in cell cycle regulation, transcriptional activation and signal transduction of tumor development. For example, COPS5 promotes the degradation of p27, an inhibtor of cyclin E-Cdk2, through accelerating its translocation from the nucleus to the cytoplasm. 32, 33 COPS5 is also involved in ubiquitination and degradation of tumor-inhibiting factors including P53 and Smad4/7. 28, 34 Limited studies available indicated that COPS5 could participate in cell proliferation, invasiveness and poor prognosis of CRC. [35] [36] [37] In our study, overexpression of COPS5 has been confirmed in both CRC tissues and cell lines. Since the higher expression of COPS5 was found in metastatic CRC originated cell lines compared to that in nonmetastatic originated CRC cell lines, COPS5 might be a CRC metastasis enhancer. CCK8 assay, clone formation experiments and cell cycle analysis added evidences to the stimulatory role of COPS5 on CRC cell proliferation. Lung colonization assay, wound-healing and trans-well migration assay demonstrated an activation of cell migration, invasion and metastasis in COPS5 overexpressed CRC cells.
Although we have verified the direct interaction between LASP1 and COPS5, no regulatory relationship was found between two proteins. In our previous study, LASP1 was verified interacting with 14-3-3r and negatively regulated the expression of 14-3-3r. 18 Since LASP1 has no protein degradation capacity, other LASP1-interacted protein might contribute to the downregulation of 14-3-3r at protein level. As a multifunctional protein, COPS5, was proposed to be involved in LASP1 modulated expression of 14-3-3r. The existence of interaction among three proteins was confirmed by Co-IP. A series of gain-and loss-of-function assays indicated that COPS5 and LASP1 protein complex could interact synergistically to influence the stability of 14-3-3r. Moreover, high COPS5 expression is usually accompanied with high LASP1 expression but low expression of 14-3-3r in IHC conducted with CRC tissues. 38 Since COPS5 is well-characterized to be involved in ubiquitin-mediated protein degradation 39, 40 we studied the effects of COPS5 on the ubiquitination and degradation of 14-3-3r. As expected, COPS5 dramatically stimulated the ubiquitination of 14-3-3r, as well as the following protein degradation. The COPS5 induced degradation of 14-3-3r was totally recovered with the existence of MG132, which reduces the degradation of ubiquitin-conjugated proteins. Our results supported that COPS5 should play a vital role in LASP-1 mediated downregulation of 14-3-3r and the following CRC progression.
As PI3K/Akt signaling pathway was activated in LASP1/ 14-3-3r-mediated CRC progression, 12, 18 this pathway was also studied in COPS5 mediated CRC progression. In the present study, si-LASP1 could not only restore COPS5-suppressed expression of 14-3-3r but also inhibit COPS5-activated phosphorylation of Akt. A consistent result was obtained when silencing COPS5 in LASP1-overexpressed CRC cells. LY29004, the inhibitor of PI3K/Akt pathway, further confirmed the involvement of PI3K/Akt pathway in COPS5 mediated CRC cell progression. All the results above suggested the synergistic role of COPS5 and LASP1 on the expression of 14-3-3r, and the involvement of PI3K/Akt Pathway. Besides PI3K/Akt signaling pathway, we also detected the activation of MAPK signal pathway in COPS5-overexpressed CRC cells. Moreover, Wnt/b-catenin signal pathway was also verified participated in COPS5 stimulated CRC cell progression. 37 To investigate the expression of COPS5 in CRC tissues, IHC was conducted on clinical CRC samples with paired normal colorectal mucosa. COPS5 was highly expressed in CRC tissues, especially in advanced CRC samples. In accordance with the previous study, 35 expression of COPS5 was correlated with differentiation, TNM stage and lymph node metastasis of CRC. Multivariate analysis was used to further analyze the predictive value of COPS5 on CRC prognosis, and results do not propose the expression of COPS5 as an independent prognostic factor. In view of the similar effects of LASP1 on CRC patient survival, 9 we combined COPS5 and LASP1 to evaluate their predictive value. Interestingly, the combination of COPS5 and LASP1 tends to be an independent prognostic factor, and it is also suitable for CRC without lymph node metastasis. It will undoubtedly improve diagnostic and therapeutic strategies of early stage CRC. In summary, our results investigated a synergistically role of COPS5 in LASP1-mediated CRC metastasis. COPS5 could directly bind to the SH3 domain of LASP1, and negatively regulated the expression of 14-3-3r through ubiquitination and the following protein degradation. Silencing of COPS5 markedly suppressed LASP1/14-3-3r-mediated cell migration through phosphorylating AKT and activating PI3K/AKT signaling pathway (Fig. 6d) . Studies on clinical samples indicated the involvement of COPS5 in CRC metastasis, and COPS5 was correlated with the worse outcome of CRC patients. The combination of COPS5 and LASP1 was proven to be an independent prognostic factor and this is also suitable for CRC patients without lymph node metastasis. Therefore, the current research has not only improved our understanding on the essential role of COPS5 in LASP1-mediated CRC progression but also provided a promising target for novel diagnostic and therapeutic strategies in CRC.
